RGEN Repligen Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:22
May 28
May 28
The author replies with tickers DIM and RGEN in response to a question about names they like, but provides no explicit position or forward call.
16:22
May 28
May 28
Speaker lists RGEN as a pureplay with more upside versus diversified medtech names like TMO/DHR; no concrete catalyst provided, rhetorical list context per known speaker style.
LOW
03:01
May 06
May 06
The author compares current semiconductor mania to the COVID-era biopharma bubble, warning that overextrapolation of innovation led to massive losses, implying similar risk for semis now.
HIGH
02:56
May 06
May 06
The author compares current semiconductor mania to the COVID-era life sciences bubble, warning that overhyped assumptions could lead to a similar crash.
HIGH
01:01
May 01
May 01
The author is bullish on bioprocessing and specifically recommends $DIM.FP as a long position due to equipment torque, attractive multiples, and tailwinds from onshoring CAPEX, biosimilars, and AI-driven innovation.
HIGH
14:02
Mar 17
Mar 17
The author suggests that the life sciences sector has reached a market floor.
19:55
Mar 14
Mar 14
The tweet implies positive growth prospects for the bioprocessing sector.
About RGEN Analyst Coverage
Buzzberg tracks RGEN (Repligen) across 1 sources. 2 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (29%). 7 total trade ideas tracked. Latest voices: TheLAPurchaser.